Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry.

Bezerra CG, Adam EL, Baptista ML, Ciambelli GS, Kopel L, Bernoche C, Lopes LN, Macatrão-Costa MF, Falcão Bde A, Lage SG.

Arq Bras Cardiol. 2016 Jan;106(1):26-32. doi: 10.5935/abc.20150147. Epub 2015 Dec 22. English, Portuguese.

2.

The role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.

Kirbiš S, Gorenjak M, Sinkovič A.

BMC Cardiovasc Disord. 2015 Jun 13;15:49. doi: 10.1186/s12872-015-0054-9.

3.

Prognostic value of pentraxin-3 level in patients with STEMI and its relationship with heart failure and markers of oxidative stress.

Tomandlova M, Jarkovsky J, Tomandl J, Kubkova L, Kala P, Littnerova S, Gottwaldova J, Kubena P, Ganovska E, Poloczek M, Spinar J, Mueller C, Mebazaa A, Pavkova Goldbergova M, Parenica J.

Dis Markers. 2015;2015:159051. doi: 10.1155/2015/159051. Epub 2015 Apr 1.

4.

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.

Fuernau G, Pöss J, Denks D, Desch S, Heine GH, Eitel I, Seiler S, de Waha S, Ewen S, Link A, Schuler G, Adams V, Böhm M, Thiele H.

Crit Care. 2014 Dec 21;18(6):713. doi: 10.1186/s13054-014-0713-8.

5.

Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry.

Aissaoui N, Puymirat E, Simon T, Bonnefoy-Cudraz E, Angoulvant D, Schiele F, Benamer H, Quandalle P, Prunier F, Durand E, Berard L, Blanchard D, Danchin N.

Crit Care. 2014 Sep 19;18(5):516. doi: 10.1186/s13054-014-0516-y.

6.

FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock.

Pöss J, Mahfoud F, Seiler S, Heine GH, Fliser D, Böhm M, Link A.

Eur Heart J Acute Cardiovasc Care. 2013 Sep;2(3):211-8. doi: 10.1177/2048872613494025.

7.

Therapeutic strategies for high-dose vasopressor-dependent shock.

Bassi E, Park M, Azevedo LC.

Crit Care Res Pract. 2013;2013:654708. doi: 10.1155/2013/654708. Epub 2013 Sep 15. Review.

8.

The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis.

Pirracchio R, Parenica J, Resche Rigon M, Chevret S, Spinar J, Jarkovsky J, Zannad F, Alla F, Mebazaa A; GREAT network.

PLoS One. 2013 Aug 15;8(8):e71659. doi: 10.1371/journal.pone.0071659. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/add6bc4f-dec0-4c95-a609-67563469b831.

9.

Kinetic of procalcitonin in patients with cardiogenic shock following acute myocardial infarction: preliminary data.

Picariello C, Lazzeri C, Chiostri M, Gensini GF, Valente S.

HSR Proc Intensive Care Cardiovasc Anesth. 2010;2(3):201-7.

10.

Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.

Sjauw KD, Engström AE, Vis MM, Boom W, Baan J Jr, de Winter RJ, Tijssen JG, Piek JJ, Henriques JP.

Neth Heart J. 2012 Oct;20(10):402-9. doi: 10.1007/s12471-012-0312-8.

11.

Translating metabolomics to cardiovascular biomarkers.

Senn T, Hazen SL, Tang WH.

Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):70-6. doi: 10.1016/j.pcad.2012.06.004. Review.

12.

Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.

Truffa AA, Granger CB, White KR, Newby LK, Mehta RH, Hochman JS, Patel MR, Pieper KS, Al-Khalidi HR, Armstrong PW, Lopes RD.

JACC Cardiovasc Interv. 2012 Jul;5(7):769-76. doi: 10.1016/j.jcin.2012.03.018.

13.
14.

Middle cerebral artery resistivity and pulsatility indices in systemic lupus erythematosus: evidence for hyperperfusion.

Greene ER, Yonan KA, Sharrar JM, Sibbitt WL Jr, Roldan CA.

Lupus. 2012 Apr;21(4):380-5. doi: 10.1177/0961203311428458. Epub 2011 Nov 29.

15.

Percutaneous ventricular assist devices: new deus ex machina?

Arroyo D, Cook S.

Minim Invasive Surg. 2011;2011:604397. doi: 10.1155/2011/604397. Epub 2011 Jul 31.

16.

Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.

Hasslacher J, Bijuklic K, Bertocchi C, Kountchev J, Bellmann R, Dunzendorfer S, Joannidis M.

Crit Care. 2011 Jul 12;15(4):R166. doi: 10.1186/cc10307.

17.

Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials.

Jeger RV, Urban P, Harkness SM, Tseng CH, Stauffer JC, Lejemtel TH, Sleeper LA, Pfisterer ME, Hochman JS.

Acute Card Care. 2011 Mar;13(1):14-20. doi: 10.3109/17482941.2010.538696. Epub 2011 Jan 18.

18.

Bench-to-bedside review: nitric oxide in critical illness--update 2008.

Hollenberg SM, Cinel I.

Crit Care. 2009;13(4):218. doi: 10.1186/cc7706. Epub 2009 Jul 16. Review.

19.

Using systems biology to simplify complex disease: immune cartography.

Polpitiya AD, McDunn JE, Burykin A, Ghosh BK, Cobb JP.

Crit Care Med. 2009 Jan;37(1 Suppl):S16-21. doi: 10.1097/CCM.0b013e3181920cb0.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk